| Primary |
| Colorectal Cancer Metastatic |
26.3% |
| Gastric Cancer |
14.8% |
| Oesophageal Carcinoma |
12.7% |
| Breast Cancer |
8.3% |
| Colorectal Cancer |
5.3% |
| Oesophageal Squamous Cell Carcinoma |
3.6% |
| Head And Neck Cancer |
3.4% |
| Colon Cancer |
3.2% |
| Cervix Carcinoma |
3.0% |
| Anal Squamous Cell Carcinoma |
2.5% |
| Cervix Carcinoma Stage Iv |
2.1% |
| Laryngeal Cancer |
2.1% |
| Hypopharyngeal Cancer |
2.0% |
| Hepatic Neoplasm Malignant |
1.8% |
| Rectal Cancer |
1.8% |
| Anal Cancer |
1.7% |
| Metastatic Gastric Cancer |
1.7% |
| Adenocarcinoma |
1.5% |
| Choriocarcinoma |
1.2% |
| Colon Cancer Metastatic |
1.1% |
|
| Neutropenia |
16.3% |
| Vomiting |
10.9% |
| Febrile Neutropenia |
8.7% |
| Thrombocytopenia |
8.2% |
| Toxicity To Various Agents |
8.2% |
| Anaemia |
6.0% |
| Diarrhoea |
5.4% |
| Haematotoxicity |
3.8% |
| Leukopenia |
3.8% |
| Mucosal Inflammation |
3.8% |
| Infection |
3.3% |
| Decreased Appetite |
2.7% |
| Diabetes Mellitus |
2.7% |
| Fatigue |
2.7% |
| Sepsis |
2.7% |
| Death |
2.2% |
| Neuropathy Peripheral |
2.2% |
| Pyrexia |
2.2% |
| Stomatitis |
2.2% |
| White Blood Cell Count Decreased |
2.2% |
|
| Secondary |
| Breast Cancer |
24.6% |
| Product Used For Unknown Indication |
16.4% |
| Colorectal Cancer Metastatic |
13.0% |
| Chemotherapy |
8.7% |
| Metastatic Colorectal Cancer |
8.7% |
| Colon Cancer |
3.9% |
| Colon Cancer Metastatic |
3.4% |
| Adenocarcinoma Of Colon |
2.4% |
| Colorectal Cancer |
2.4% |
| Neoplasm |
2.4% |
| Colorectal Cancer Metastatic |
1.9% |
| Metastases To Liver |
1.9% |
| Adenocarcinoma Of Colon Stage Iv |
1.4% |
| Adenocarcinoma Pancreas |
1.4% |
| Pharyngeal Disorder |
1.4% |
| Rectal Cancer |
1.4% |
| Small Intestine Carcinoma |
1.4% |
| Diabetes Mellitus |
1.0% |
| Adenocarcinoma Of The Gastroesophageal Junction |
1.0% |
| Drug Use For Unknown Indication |
1.0% |
|
| Neutropenia |
15.8% |
| Rash |
10.5% |
| Paraesthesia |
7.9% |
| Pulmonary Fibrosis |
7.9% |
| Thrombocytopenia |
7.9% |
| Myocardial Infarction |
5.3% |
| Neuropathy Peripheral |
5.3% |
| Pneumonia |
5.3% |
| Upper Respiratory Tract Infection |
5.3% |
| Atrial Fibrillation |
2.6% |
| Back Pain |
2.6% |
| Bone Marrow Failure |
2.6% |
| Bronchopneumonia |
2.6% |
| Epistaxis |
2.6% |
| Febrile Neutropenia |
2.6% |
| Gamma-glutamyltransferase Increased |
2.6% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Hepatic Failure |
2.6% |
| Hyperbilirubinaemia |
2.6% |
| Hypertension |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.3% |
| Colon Cancer Metastatic |
23.5% |
| Colon Cancer |
11.8% |
| Breast Cancer |
5.9% |
| Colorectal Cancer |
5.9% |
| Prophylaxis Of Nausea And Vomiting |
5.9% |
| Rectal Adenocarcinoma |
5.9% |
| Rectal Cancer |
5.9% |
|
| Rash |
15.4% |
| Thrombotic Thrombocytopenic Purpura |
15.4% |
| Hyperammonaemic Encephalopathy |
7.7% |
| Hypotension |
7.7% |
| Infusion Related Reaction |
7.7% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
7.7% |
| Renal Failure Acute |
7.7% |
| Scotoma |
7.7% |
| Thrombocytopenia |
7.7% |
| Upper Gastrointestinal Haemorrhage |
7.7% |
| Urticaria |
7.7% |
|
